Mesenchymal stem cells for neurological disorders

A Andrzejewska, S Dabrowska, B Lukomska… - Advanced …, 2021 - Wiley Online Library
Neurological disorders are becoming a growing burden as society ages, and there is a
compelling need to address this spiraling problem. Stem cell‐based regenerative medicine …

Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory …

S Gänger, K Schindowski - Pharmaceutics, 2018 - mdpi.com
The blood-brain barrier and the blood-cerebrospinal fluid barrier are major obstacles in
central nervous system (CNS) drug delivery, since they block most molecules from entering …

[HTML][HTML] Nanosystems for the encapsulation of natural products: The case of chitosan biopolymer as a matrix

A Detsi, E Kavetsou, I Kostopoulou, I Pitterou… - Pharmaceutics, 2020 - mdpi.com
Chitosan is a cationic natural polysaccharide, which has emerged as an increasingly
interesting biomaterialover the past few years. It constitutes a novel perspective in drug …

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research

AJ Guastella, IB Hickie, MM McGuinness, M Otis… - …, 2013 - Elsevier
A series of studies have reported on the salubrious effects of oxytocin nasal spray on social
cognition and behavior in humans, across physiology (eg, eye gaze, heart rate variability) …

Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles

E Ahmad, Y Feng, J Qi, W Fan, Y Ma, H He, F Xia… - Nanoscale, 2017 - pubs.rsc.org
The nose-to-brain pathway has been proven to be a shortcut for direct drug delivery to the
brain. However, whether and to what extent nanoparticles can be delivered through this …

Recent advances in protein and peptide drug delivery: a special emphasis on polymeric nanoparticles

A Patel, M Patel, X Yang, A K. Mitra - Protein and peptide letters, 2014 - benthamdirect.com
Proteins and peptides are widely indicated in many diseased states. Parenteral route is the
most commonly em-ployed method of administration for therapeutic proteins and peptides …

Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules

A Fortuna, G Alves, A Serralheiro, J Sousa… - European Journal of …, 2014 - Elsevier
As a non-invasive route, intranasal administration offers patient comfort and compliance
which are hurdled in parenteral drug therapy. In addition, the current recognition that the …

Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model

DS Quintana, GA Alvares, IB Hickie… - … & Biobehavioral Reviews, 2015 - Elsevier
Accumulating evidence demonstrates the important role of oxytocin (OT) in the modulation of
social cognition and behavior. This has led many to suggest that the intranasal …

Chitosan-coated nanoparticles: Effect of chitosan molecular weight on nasal transmucosal delivery

FA Bruinsmann, S Pigana, T Aguirre, G Dadalt Souto… - Pharmaceutics, 2019 - mdpi.com
Drug delivery to the brain represents a challenge, especially in the therapy of central
nervous system malignancies. Simvastatin (SVT), as with other statins, has shown potential …

Nasal-nanotechnology: revolution for efficient therapeutics delivery

A Kumar, AN Pandey, SK Jain - Drug delivery, 2016 - Taylor & Francis
Context: In recent years, nanotechnology-based delivery systems have gained interest to
overcome the problems of restricted absorption of therapeutic agents from the nasal cavity …